Protagenic Therapeutics's total assets for Q2 2025 were $6.49M, an increase of 556.27% from the previous quarter. PTIX total liabilities were $10.46M for the fiscal quarter, a 871.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.